Advertisement · 728 × 90

Posts by Manuel Kaulich

Post image

Excited host @hohmannulrich.bsky.social from @imbmainz.bsky.social, along with @manuelkaulich.bsky.social

Date: 07.04.2026
Time: 15:00
Venue: Haus 22 Seminar Room 1. (S22-1)

Title: ‘Mechanistic insights into nuclear mRNA export and degradation’
@goetheuni.bsky.social @cpi-exstra.bsky.social

3 weeks ago 16 8 0 2

A fantastic line up of speakers.

Hope to see many of you in wonderful Mainhatten (Frankfurt).

4 weeks ago 2 1 0 0
Preview
Targeting ubiquitin signaling vulnerabilities in KEAP1-inactivated lung cancer - The EMBO Journal Lung cancer cells rely on protein homeostasis regulators, particularly the ubiquitin-proteasome system (UPS), to sustain malignancy. Genetic alterations in UPS components, such as E3 ubiquitin ligases...

Happy to share another paper from the lab.

While KEAP1 is often mutated in aggressive lung cancer, its loss can paradoxically suppress tumor growth in certain contexts by inducing Nrf2-driven reductive stress.

link.springer.com/article/10.1...

1 month ago 2 3 0 0
Video

How do immune disease-relevant variants rewire gene regulation in CD4+ T cells?
In a collaboration led by Daniel Schraivogel and Lars Steinmetz at @embl.org, we combined two large-scale CRISPRi screens (4.1M cells) to map the downstream cascades of thousands of SNPs.

1 month ago 13 9 1 0

Out now on bioRxiv! 🧬🖥️

Dewi Moonen, @anniquec.bsky.social and a team led by Lars Steinmetz and Daniel Schraivogel at EMBL have mapped the downstream regulatory networks of thousands of immune disease-relevant variants in CD4+ T cells

www.biorxiv.org/content/10.6...

1 month ago 14 3 1 0

Very proud to see this work out on bioRxiv. Using genome-scale TAP/Perturb-seq we mapped the function of immune-disease variants to target genes and regulatory cascades. Have a look at the 🧵from @anniquec.bsky.social for more info!

1 month ago 7 3 0 0

So great to this preprint out.

It was/is such a pleasure to work with this fantastic team.

Congratulations to all of you!

1 month ago 3 0 0 0

Congrats. That’s a great story!

1 month ago 1 0 1 0

Our preprint is published in MSB! This time with the correct preprint post below! link.springer.com/article/10.1...

1 month ago 6 6 1 0
Preview
Die Genschere in Dresden, 26.3.2026 bis 29.3.2026 - CRISPR-Whisper Die „CRISPR-Roadshow“ ist ein Projekt des Forschungskonsortiums SPP2141, mit dem Wissenschaft für jedermann verständlich und erlebbar wird. Der SPP2141 ist eine Gruppe von 20 Forschungslaboren, die vo...

The public event "CRISPR Gene scissors in Dresden" is taking place March 26 to 29. The "CRISPR-Roadshow" is teaming up with partners @mpi-cbg.de, @tudresden.bsky.social, and @crtd-tud.bsky.social for a wide range of activities on the CRISPR/Cas method. www.crispr-whisper.de/2025/10/01/d...

1 month ago 8 6 0 2
Advertisement

Insights from the 2nd EuroDepMap Symposium are now out in FEBS Letters.
Last November at Human Technopole researchers in cancer functional genomics and computational biology discussed challenges and future directions in mapping cancer vulnerabilities and building predictive frameworks.
Link ⬇️

1 month ago 3 2 1 0
Preview
FEBS Press Held on 20 November 2025 at Human Technopole in Milan, the 2nd European Cancer Dependency Map Symposium convened experimental and computational scientists to discuss how cancer dependency mapping in ...

Our thoughts, impressions, and presentations of the "2nd EuroDepMap symposium" in Milan (Nov 2025) are online at
@febsletters.bsky.social.

febs.onlinelibrary.wiley.com/doi/10.1002/...

1 month ago 4 8 0 0

You know your crowed…… thanks for sharing - will take a deep dive.

3 months ago 1 0 0 0
2nd European Cancer Dependency Map Symposium - 20 Nov 2025
2nd European Cancer Dependency Map Symposium - 20 Nov 2025 YouTube video by Human Technopole

💫 Thank you to all participants and speakers who joined us at the 2nd @eurocancerdepmap.bsky.social Symposium!

Together, we’re advancing #cancer functional genomics across Europe.

youtu.be/Qt_ozbzM5js

5 months ago 6 5 1 0
Start of the second session of the 2nd EuroCancerDepMap symposium with a talk from Manuel Kaulich

Start of the second session of the 2nd EuroCancerDepMap symposium with a talk from Manuel Kaulich

The Synthetic Lethality and Innovations in CRISPR Screening session begins with @manuelkaulich.bsky.social telling us about exciting CRISPR libraries they have developed and how nuclear mRNA processing can mask the CRISPRko phenotypes @eurocancerdepmap.bsky.social

5 months ago 12 4 0 0
Beeswarm plot of the prediction error across different methods of double perturbations showing that all methods (scGPT, scFoundation, UCE, scBERT, Geneformer, GEARS, and CPA) perform worse than the additive baseline.

Beeswarm plot of the prediction error across different methods of double perturbations showing that all methods (scGPT, scFoundation, UCE, scBERT, Geneformer, GEARS, and CPA) perform worse than the additive baseline.

Line plot of the true positive rate against the false discovery proportion showing that none of the methods is better at finding non additive interactions than simply predicting no change.

Line plot of the true positive rate against the false discovery proportion showing that none of the methods is better at finding non additive interactions than simply predicting no change.

Our paper benchmarking foundation models for perturbation effect prediction is finally published 🎉🥳🎉

www.nature.com/articles/s41...

We show that none of the available* models outperform simple linear baselines. Since the original preprint, we added more methods, metrics, and prettier figures!

🧵

8 months ago 125 57 2 6
Preview
Announcement of Clusters of Excellence to Receive Funding in the Future, Thursday, 22 May 2025, from approx. 5 pm

In times when science must defend itself, the decision by the German Research Foundation (DFG) to significantly support German universities through the Excellence Initiative for the next seven years is a signal that stands unparalleled.

www.dfg.de/en/news/news...

10 months ago 0 0 0 0

Such a wonderful example of what genetic screens can tell us about human patho/physiology.

Cudos @mgarnett.bsky.social, Fiona Behan and many more.

11 months ago 0 0 0 0
Advertisement

Congratulations! & thanks for letting us contribute to this wonderful story.

11 months ago 2 0 0 0
Post image
1 year ago 104914 16373 824 559

Congratulations. On top of my reading list.

1 year ago 1 0 0 0
Preview
Deutschlandtrend der ARD: Nur 16 Prozent halten USA noch für vertrauenswürdig Bleiben die USA der wichtigste Verbündete Europas? Die große Mehrheit in Deutschland glaubt einer Umfrage zufolge offenbar nicht mehr an eine gute Zusammenarbeit.

A record low…. only 16% of Germans think that Germany can trust the US.

A record fast…. never before lost a US president support for its political agenda that fast.

www.spiegel.de/politik/deut...

1 year ago 0 0 0 0

If a team wished to include combinatorial gene perturbation and bioinformatics in their program, please reach out.

1 year ago 4 3 0 0
Post image

New Gordon Research Conference Alert: Synthetic Lethality Approaches in Oncology. www.grc.org/synthetic-le....

Join us 20-25th July 2025 for an intimate meeting with thought leaders in the field. Great for networking and opportunities for early career scientists to present their research.

1 year ago 5 8 0 0

80% of Germans (84% participation) voted for democracy.

#TogetherAgainstPopulism

1 year ago 0 0 0 0
2025 Synthetic Lethality Approaches in Oncology Conference GRC The 2025 Gordon Research Conference on Synthetic Lethality Approaches in Oncology will be held in Portland, Maine. Apply today to reserve your spot.

Interested in synthetic lethality or how functional genomics can be leveraged for clinical benefit?

Then, this is the place to meet:

www.grc.org/synthetic-le...

1 year ago 1 1 0 0

If you search for unexpected phenotypes (genetic interactions), aren't they expected when observed? 🤔

1 year ago 0 0 0 0
Advertisement

Which rate do you consider appropriate,

10% or 1% ?

1 year ago 0 0 0 0

Thinking about grant alternatives to fund basic research?

Provocative thought - How about getting a royalty rate per accessed publication (per corresponding author)?

1 year ago 1 0 0 1
2025 Synthetic Lethality Approaches in Oncology Conference GRC The 2025 Gordon Research Conference on Synthetic Lethality Approaches in Oncology will be held in Portland, Maine. Apply today to reserve your spot.

📣Registration is now open for an exciting Gordon Conference on synthetic lethality organized by Ben Schwartz (GSK), Mathew Garnett (Sanger), and Francisca Vazquez (DepMap Director, Broad Institute)

Highly recommended!

Register here
grc.org/synthetic-le...

1 year ago 4 4 0 0